Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. root
  2. FIRAZYR (icatibant (acétate d'))
  • icone plus
  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte
  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités
Listen Listen
Add to my selection
  • History
  • Technical informations
Share
Share on
Facebook share - facebook.com - new window
Tweeter share - Partager sur Twitter - twitter.com - new window
LinkedIn share - linkedin.com - new window
Print

FIRAZYR (icatibant (acétate d'))

Medicine - Posted on Feb 08 2019 - Updated on Jun 12 2019
Active substance (DCI)
  • icatibant (acétate d')
history (4)
  • 7/25/18

    FIRAZYR (icatibant)

    High clinical benefit in their respective indications, but no demonstrated clinical advantage, with the exception of BERINER...
    CAV :
    54321
    icône flèche
  • 7/25/18

    FIRAZYR (icatibant (acétate d'))

    FIRAZYR (icatibant (acétate d'))
    CAV :
    54321
    icône flèche
  • 1/4/12

    FIRAZYR (icatibant (acétate d'))

    FIRAZYR (icatibant (acétate d'))
    icône flèche
  • 11/26/08

    FIRAZYR

    FIRAZYR (icatibant), antagoniste des récepteurs B2 de la bradykinine Progrès thérapeutique mineur dans la prise en charge de...
    CAV :
    54321
    icône flèche
Technical information
ATC code
  • B06AC02
Manufacturer
SHIRE FRANCE S.A.
Presentation

FIRAZYR 10 mg/ml, solution injectable Boîte de 1 seringue de 3 ml, code CIP : 387 368-0

FIRAZYR 30 mg, solution injectable en seringue pré-remplie (code CIS : 61680479) 1 seringue(s) préremplie(s) en verre de 3 ml avec aiguille(s) - Code CIP : 3400938736809

All our publications
    Congenital, genetic and rare diseases Drug therapy Heart failure Immune system diseases - miscellaneous Metabolic diseases Paediatrics Peripheral vascular diseases Skin and connective tissue diseases Vascular diseases - miscellaneous

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
VNAgsNZ0MS4R0Njh